Guest guest Posted February 4, 2004 Report Share Posted February 4, 2004 As follow up to my posting this A.M. I have included the article refered to by someone last week. Looks promising. Tom Archive Classified Shopping Promotions Games Fast Times My Times Weather SEARCH HEALTH Health news Health features Health briefings Health alternatives Health diet Health fitness Health industry TIMES ONLINE Home Breaking news Britain World Sport Business Your Money Comment Sports Book Travel Entertainment Shopping Law Classifieds Games Crossword Motoring Property Health Student Weather Sunday Times NEWSPAPER Monday Tuesday Wednesday Thursday Friday Saturday Sunday QUICK CLICKS Appointments Arts Books Charity Appeal Contact Us Creme Education Encounters Fast Times Finest First night Food and drink From the Archive Good University Guide Online Specials Photosales Promotions Public Agenda Style Guide Supplements Talking Point The Register Times e-mail Times 2 Times Services Weekend Review SPECIAL REPORTS Investor's Centre Business insurance Unplugged Office Highly Developed CRM Public Sector CRM for Business Business Travel Health news January 25, 2004 The Sunday TimesGoat serum jabs help MS victims to walk againby Nick Fielding PATIENTS suffering from multiple sclerosis (MS), the incurable wasting disease, have experienced dramatic improvements in their condition after taking part in trials of a drug derived from goat serum. Some have reported being able to cast aside their walking sticks and walk for miles, or of regaining their vision or finding they can again use their limbs after years when any movement was agony. Of the 130 patients on the trial, 85% reported big improvements with no side effects. Among them is Edmiston, of Southsea, who was diagnosed with MS in 1988. “At the time of my first injections 15 months ago I was using walking sticks and sometimes a wheelchair. I started this treatment with no expectations but it has been astonishing,” he said. “I am 500% better than I was. I can walk for several miles without sticks. I’m much stronger and generally healthier. And you have to remember that we have always been told that there may be remissions, but that the progress of the disease is unstoppable.” The success of the trials has started to gain international recognition with Alan Osmond, one of America’s leading campaigners about the disease, travelling from the US to take the drug. Osmond, the eldest member of the Osmonds singing group, who was diagnosed with the disease 17 years ago, said: “When I heard about the treatment here I decided I would have to come and see for myself.” MS is the most common chronic disease of the central nervous system in young adults, affecting millions of people worldwide. Most cases are diagnosed between the ages of 20 and 40 and famous sufferers include the cellist du Pré, the actor Pryor, director Forbes and Tory whip Maclean. An often progressive disease of the central nervous system, MS occurs in the brain, the optic nerves and the spinal cord. Though slow in its onset, in time it may produce tremors, partial loss of sight and paralysis. The new treatment is being pioneered by a team of scientists and doctors led by Professor Angus Dalgleish, an oncologist based at St ’s hospital, Tooting, south London, who believes it will at worst provide a highly effective subjective treatment for MS sufferers, but may lead to a long-term improvement. The treatment, given as a weekly injection, is derived from purified serum from immunised goats that produce antibodies. Three separate clinical trials are now being conducted. Normally it would have taken about eight years and about £80m to get a new product to this stage. In this case it has been achieved in three years, having cost so far about £5m. Dr Maizels, a family doctor from Chiselhurst in Kent who had been treating patients in the “informed consent” trials for the past three years, said he had never seen anything like it. “I want to emphasise that this is not a placebo effect. The improvements are sustained and there are almost no side effects. At times the results are amazing,” he said. The trials, the first of which should be completed and analysed by the spring, will confirm whether there will be new hope for MS sufferers worldwide. “Being positive is the key thing,” said Osmond. “It’s not the disease that beats you, but the lack of hope.” ALSO IN THIS SECTION Listeria found in smoked salmon Goat serum jabs help MS victims to walk again Koo loses second breast Irish dental tourists fly to Budapest Harney rebuked over elderly care Comment: Hjul: Society must realise that no anonymity means no donors READER OFFERS SPORTS SHOPSpecial offers every week, and great deals on a full range of sports equipment......................................... SHOPPINGVisit Times Online Shopping for shirts, software, tickets, lingerie, wine and much much more ......................................... BOOKSVisit the book shop, for great offers from The Times and Sunday Times ......................................... TOOLS & SERVICES Time OutFor activity holidays or pure relaxation, search our travel classified ads for your next break......................................... Health InsuranceUse our Life Assurance finder to compare over 100 policies and find the best one for you......................................... ClassifiedTimes Online brings you the best of public sector jobs, as advertised in The Times and The Sunday Times......................................... ADVERTISEMENT GAMES FANTASY SHARESFree to play: £1million in fantasy money; weekly-winner prizes to hot locations; set up a syndicate to win trip for ten to Amsterdam ......................................... FANTASY FOOTBALL£150,000 Times Fantasy Football - are you in the game? Click above to check your score ......................................... CROSSWORD CLUBThe world-famous Times crosswords online, plus unique access to our archive and special offers to members......................................... Contact our advertising team for advertising and sponsorship in Times Online, The Times and The Sunday Times.Copyright 2004 Times Newspapers Ltd.This service is provided on Times Newspapers' standard Terms and Conditions. Please read our Privacy Policy.To inquire about a licence to reproduce material from The Times, visit the Syndication website. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.